Showing 2,001 - 2,020 results of 12,926 for search 'CPPCC~', query time: 0.87s Refine Results
  1. 2001
  2. 2002
  3. 2003
  4. 2004
  5. 2005
  6. 2006

    The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis by Kun Meng, Yuying Li, Xiaoyi Yuan, Hui-Min Shen, Li-Ling Hu, Danya Liu, Fujin Shi, Dandan Zheng, Xinyu Shi, Nengqiao Wen, Yun Cao, Yun-Long Pan, Qing-Yu He, Chris Zhiyi Zhang

    Published 2025-01-01
    “…Here, we show that the novel protein TPM3P9, encoded by the lncRNA tropomyosin 3 pseudogene 9, exhibits oncogenic activity in clear cell renal cell carcinoma (ccRCC) by enhancing oncogenic RNA splicing. Overexpression of TPM3P9 promotes cell proliferation and tumor growth. …”
    Get full text
    Article
  7. 2007
  8. 2008
  9. 2009
  10. 2010

    Rolling Bearing Diagnosis Based on Adaptive Probabilistic PCA and the Enhanced Morphological Filter by Yuanqing Luo, Changzheng Chen, Siyu Zhao, Xiangxi Kong, Zhong Wang

    Published 2020-01-01
    “…Next, in the process of processing the test signal, in order to reduce the interference problem caused by strong background noise, the probabilistic principal component analysis (PPCA) method is introduced. In the traditional PPCA method, two important system parameters (decomposition principal component k and original variable n) are usually set artificially; this will greatly reduce the noise reduction performance of PPCA. …”
    Get full text
    Article
  11. 2011
  12. 2012
  13. 2013
  14. 2014

    Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Tre... by Jacob W. Bruinius, Karl J. Dykema, Sabrina L. Noyes, Bin Tean Teh, Brian R. Lane

    Published 2019-01-01
    “…There is sparse literature demonstrating effective treatments for metastatic chromophobe renal cell carcinoma (ChRCC). The tyrosine kinase inhibitor (TKI) sunitinib selectively inhibits the VEGF pathway and it is a standard care for metastatic clear cell renal cell carcinoma (ccRCC), although data supporting its use in ChRCC is much more limited. …”
    Get full text
    Article
  15. 2015
  16. 2016
  17. 2017
  18. 2018
  19. 2019
  20. 2020